FindTrial
Sign In

Study on the role of Dickkopf-1 in the diagnosis and prognosis of pancreatic carcinoma

Study on the role of Dickkopf-1 in the diagnosis and prognosis of pancreatic carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCC-14004957
Enrollment
Unknown
Registered
2014-07-13
Start date
2010-01-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

The First Affiliated Hospital of Xi'an Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with histologically confirmed PC were recruited according to the National Comprehensive Cancer Network (NCCN) criteria. The clinical stage was judged using the International Union Against Cancer TNM classification.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had undergone radiotherapy or chemotherapy; or had a previous history of other cancer; or were suffering acute pancreatitis when the study was initiated. Some patients were excluded if they were suffering from a mental disease.

Design outcomes

Primary

MeasureTime frame
Dickkopf-1 (DKK1);—

Contacts

Public ContactQing Zhu
newzhuqing1972@yahoo.com+86 13991822099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026